Yerkintay Guliya

Learn More
Myocardial infarction (MI) and subsequent heart failure secondary to the massive lost of cardiomyocyte is a major cause of morbidity and mortality worldwide. Given the limited endogenous potential for renewal of cardiomyocytes in adults, cardiac cell-based therapies generating new cardiomyocytes and vessels have emerged as a promising treatment to reverse(More)
  • 1